Basile Njei1,2, Thomas R McCarty3, Loren Laine1,4. 1. Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA. 2. Investigative Medicine Program, Yale Center of Clinical Investigation, New Haven, Connecticut, USA. 3. Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA. 4. Veteran Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
Abstract
BACKGROUND AND AIM: Early transjugular intrahepatic portosystemic shunt (TIPS) used as preventive therapy prior to recurrent bleeding has been recommended in patients presenting with acute esophageal variceal bleeding (EVB) who are at high risk of further bleeding and death. We investigated the impact of early TIPS on outcomes of US patients hospitalized with EVB from 2000 to 2010. METHODS: The Nationwide Inpatient Sample database was queried to identify patients with EVB and decompensated cirrhosis (because early TIPS is recommended only in high-risk patients). The primary outcome was in-hospital death, and secondary outcomes included rebleeding and hepatic encephalopathy. Early preventive TIPS was defined by placement within 3 days of hospitalization for acute EVB after one session of endoscopic therapy. Rescue TIPS was defined as TIPS after two interventions for EVB. RESULTS: The study included 142 539 patients. From 2000 to 2010, the age-adjusted in-hospital mortality rate decreased 37.2% from 656 per 100 000 to 412 per 100 000 (P <0.01), while early and rescue TIPS increased (0.22% to 0.70%; P < 0.01 and 1.1% to 6.1%; P < 0.01). On multivariate analysis, as compared with no TIPS, early TIPS was associated with decreased inpatient mortality (risk ratio [RR] = 0.87; 95% confidence interval [CI], 0.84-0.90) and rebleeding (RR = 0.56; 95% CI, 0.45-0.71) without an increase in hepatic encephalopathy (RR = 1.01; 95% CI, 0.93-1.11). CONCLUSION: Early preventive TIPS in patients with EVB and decompensated cirrhosis was associated with significant in-hospital reductions in rebleeding and mortality without a significant increase in encephalopathy in "real-world" US clinical practice.
BACKGROUND AND AIM: Early transjugular intrahepatic portosystemic shunt (TIPS) used as preventive therapy prior to recurrent bleeding has been recommended in patients presenting with acute esophageal variceal bleeding (EVB) who are at high risk of further bleeding and death. We investigated the impact of early TIPS on outcomes of US patients hospitalized with EVB from 2000 to 2010. METHODS: The Nationwide Inpatient Sample database was queried to identify patients with EVB and decompensated cirrhosis (because early TIPS is recommended only in high-risk patients). The primary outcome was in-hospital death, and secondary outcomes included rebleeding and hepatic encephalopathy. Early preventive TIPS was defined by placement within 3 days of hospitalization for acute EVB after one session of endoscopic therapy. Rescue TIPS was defined as TIPS after two interventions for EVB. RESULTS: The study included 142 539 patients. From 2000 to 2010, the age-adjusted in-hospital mortality rate decreased 37.2% from 656 per 100 000 to 412 per 100 000 (P <0.01), while early and rescue TIPS increased (0.22% to 0.70%; P < 0.01 and 1.1% to 6.1%; P < 0.01). On multivariate analysis, as compared with no TIPS, early TIPS was associated with decreased inpatient mortality (risk ratio [RR] = 0.87; 95% confidence interval [CI], 0.84-0.90) and rebleeding (RR = 0.56; 95% CI, 0.45-0.71) without an increase in hepatic encephalopathy (RR = 1.01; 95% CI, 0.93-1.11). CONCLUSION: Early preventive TIPS in patients with EVB and decompensated cirrhosis was associated with significant in-hospital reductions in rebleeding and mortality without a significant increase in encephalopathy in "real-world" US clinical practice.
Authors: Juan Carlos García-Pagán; Enric Reverter; Juan G Abraldes; Jaime Bosch Journal: Semin Respir Crit Care Med Date: 2012-03-23 Impact factor: 3.119
Authors: Joo Ha Hwang; Amandeep K Shergill; Ruben D Acosta; Vinay Chandrasekhara; Krishnavel V Chathadi; G Anton Decker; Dayna S Early; John A Evans; Robert D Fanelli; Deborah A Fisher; Kimberly Q Foley; Lisa Fonkalsrud; Terry Jue; Mouen A Khashab; Jenifer R Lightdale; V Raman Muthusamy; Shabana F Pasha; John R Saltzman; Ravi Sharaf; Brooks D Cash Journal: Gastrointest Endosc Date: 2014-08 Impact factor: 9.427
Authors: Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch Journal: N Engl J Med Date: 2010-06-24 Impact factor: 91.245
Authors: J P Cello; E J Ring; E W Olcott; J Koch; R Gordon; J Sandhu; D R Morgan; J W Ostroff; D C Rockey; P Bacchetti; J LaBerge; J R Lake; K Somberg; C Doherty; M Davila; K McQuaid; S D Wall Journal: Ann Intern Med Date: 1997-06-01 Impact factor: 25.391
Authors: Alberto Monescillo; Francisco Martínez-Lagares; Luis Ruiz-del-Arbol; Angel Sierra; Clemencia Guevara; Elena Jiménez; José Miguel Marrero; Enrique Buceta; Juan Sánchez; Ana Castellot; Mónica Peñate; Ana Cruz; Elena Peña Journal: Hepatology Date: 2004-10 Impact factor: 17.425
Authors: Juan Carlos Garcia-Pagán; Marco Di Pascoli; Karel Caca; Wim Laleman; Cristophe Bureau; Beate Appenrodt; Angelo Luca; Alexander Zipprich; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Tilman Sauerbruch; Jaime Bosch Journal: J Hepatol Date: 2012-08-30 Impact factor: 25.083
Authors: Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; David Patch; Charles Millson; Homoyon Mehrzad; Andrew Austin; James W Ferguson; Simon P Olliff; Mark Hudson; John M Christie Journal: Gut Date: 2015-04-17 Impact factor: 23.059
Authors: Jason W Wen; Michael A Kohn; Robert Wong; Ma Somsouk; Mandana Khalili; Jacquelyn Maher; Michele M Tana Journal: Am J Gastroenterol Date: 2018-01-30 Impact factor: 10.864
Authors: Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; Simon Travis; Matthew J Armstrong; Emmanuel A Tsochatzis; Ian A Rowe; Nicholas Roslund; Hamish Ireland; Mandy Lomax; Joanne A Leithead; Homoyon Mehrzad; Richard J Aspinall; Joanne McDonagh; David Patch Journal: Gut Date: 2020-02-29 Impact factor: 23.059